Herpes zoster (shingles) is a reactivation of latent Varicella-zoster virus (VZV). We present a case of pleuropericarditis simulating acute myocardial infarction and another with complete heart block in the setting of acute/recent VZV reactivation. These cases are consistent with a modified concept: (1) the VZV dormancy is comprised of multiple foci of infections in the sensory and autonomic ganglia, and (2) the VZV reactivation could involve co-incident activations of two or more loci. Recognition of this possibility of cardiovascular complications of VZV should be helpful in the clinical management of the elderly, in the differential diagnosis of chest pain, ST elevation, and heart block etiology in the setting of acute or recent VZV reactivation.

Keywords:
Herpes zoster, Varicellovirus, Pericarditis, Heart block, Autonomic ganglia
1.
Arvin AM: Varicella-zoster virus. Clin Microbiol Rev 1996;9:361–381.
2.
Hope Simpson RE: Studies on shingles: is the virus ordinary chickenpox virus? Lancet 1954;267:1299–1302.
3.
Hope-Simpson RE: The nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med 1965;58:9–20.
4.
Donahue JG, Choo PW, Manson JE, Platt R: The incidence of herpes zoster. Arch Intern Med 1995;155:1605–1609.
5.
Oxman MN, Levin MJ, Johnson GR, et al: A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005;352:2271–2284.
6.
Head H, Campbell AW: The pathology of Herpes Zoster and its bearing on sensory localization. Brain 1900;23:353–523.
7.
Gilden DH, Kleinschmidt-DeMasters BK, LaGuardia JJ, Mahalingam R, Cohrs RJ: Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med 2000;342:635–645.
8.
Arvin AM: Immune responses to varicella-zoster virus. Infect Dis Clin North Am 1996;10:529–570.
9.
Gilden DH: Varicella-zoster virus vaccine – grown-ups need it, too. N Engl J Med 2005;352:2344–2346.
10.
Spillane JD, White PD: Herpes Zoster and angina pectoris. Br Heart J 1939;1:291–302.
11.
Horton GE: Angina pectoris pain and herpes zoster: report of a case with review of the literature. Geriatrics 1965;20:78–82.
12.
Laird JM, Roza C, Cervero F: Spinal dorsal horn neurons responding to noxious distension of the ureter in anesthetized rats. J Neurophysiol 1996;76:3239–3248.
13.
Roza C, Laird JM, Cervero F: Spinal mechanisms underlying persistent pain and referred hyperalgesia in rats with an experimental ureteric stone. J Neurophysiol 1998;79:1603–1612.
14.
Gilden DH, Katz RI: Surgical induction of zoster in a contralateral homologous dermatomal distribution. Arch Neurol 2003;60:616–617.
15.
Cheatham WJ: The relation of heretofore unreported lesions to pathogenesis of herpes zoster. Am J Pathol 1953;29:401–411.
16.
Gilden DH, Gesser R, Smith J, et al: Presence of VZV and HSV-1 DNA in human nodose and celiac ganglia. Virus Genes 2001;23:145–147.
17.
Nomdedeu JF, Nomdedeu J, Martino R, et al: Ogilvie’s syndrome from disseminated varicella-zoster infection and infarcted celiac ganglia. J Clin Gastroenterol 1995;20:157–159.
18.
Harper DR, Grose C: IgM and IgG responses to varicella-zoster virus p32/p36 complex after chickenpox and zoster, congenital and subclinical infections, and vaccination. J Infect Dis 1989;159:444–451.
19.
Hope-Simpson RE: Herpes zoster – a parasitic fossil. Nurs Times 1976;72:262–265.
20.
Mazur MH, Dolin R: Herpes zoster at the NIH: a 20 year experience. Am J Med 1978;65:738–744.
21.
Horten B, Price RW, Jimenez D: Multifocal varicella-zoster virus leukoencephalitis temporally remote from herpes zoster. Ann Neurol 1981;9:251–266.
22.
Franken RA, Franken M: Pseudo-myocardial infarction during an episode of herpes zoster. Arq Bras Cardiol 2000;75:523–530.
23.
Novikov Iu I, Kotliarova LA: Acute myopericarditis in herpes zoster. Klin Med (Mosk) 1986;64:138–140.
24.
Gilden DH, Lipton HL, Wolf JS, et al: Two patients with unusual forms of varicella-zoster virus vasculopathy. N Engl J Med 2002;347:1500–1503.
© 2007 S. Karger AG, Basel
2006
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.